JERUZALĖS VAISTINĖ - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 168,967 | 192,120 | 209,905 | 171,362 | 142,257 | 133,187 | 123,575 | 59,578 |
| Profit before tax | -255 | 4,891 | 15,643 | 6,653 | 5,525 | - | - | - |
| Net profit | -255 | 4,891 | 15,248 | 6,320 | 5,249 | 222 | -3,316 | -8,372 |
| Equity | -9,447 | -4,556 | 10,693 | 17,013 | 22,262 | 22,484 | 14,896 | 6,524 |
| Liabilities | 35,722 | 40,471 | 25,915 | 37,015 | 31,842 | 37,270 | 28,005 | 0 |
| Non-current assets | 31 | 0 | 0 | 1,121 | 831 | 541 | 250 | 0 |
| Current assets | 26,244 | 35,915 | 36,608 | 52,907 | 53,273 | 59,213 | 42,651 | 6,524 |
| Total assets | 26,275 | 35,915 | 36,608 | 54,028 | 54,104 | 59,754 | 42,901 | 6,524 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 4,209 | 4,092 | 3,461 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +10.3% | +13.7% | +9.3% | -18.4% | -17.0% | -6.4% | -7.2% | -51.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -1.0% | 13.6% | 41.7% | 11.7% | 9.7% | 0.4% | -7.7% | -128.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | 142.6% | 37.1% | 23.6% | 1.0% | -22.3% | -128.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -0.2% | 2.5% | 7.3% | 3.7% | 3.7% | 0.2% | -2.7% | -14.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -0.2% | 2.5% | 7.5% | 3.9% | 3.9% | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | 2.4 | 2.2 | 1.4 | 1.7 | 1.9 | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 39,757 | 64,040 | 69,968 | 62,313 | 71,129 | 57,081 | 41,192 | 19,859 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
JERUZALĖS VAISTINĖ - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-09-18 | 2023-09-18 | 12.60 |
JERUZALĖS VAISTINĖ - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company JERUZALĖS VAISTINĖ is: 0 €
| From | To | Overdue, € |
|---|---|---|
| 2026-02-27 | 2026-09-02 | 0.01 |
| 2026-02-21 | 2026-02-26 | 226.0 |
| 2025-08-28 | 2025-09-08 | 0.02 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
JERUZALES VAISTINE, UAB is a Private Limited Liability Company, registered under code 223284490, operating in the retail sale of pharmaceutical products. In 2025, the company generated revenue of €59.6K, down from €123.6K in 2024 and €133.2K in 2023, showing a marked two-year contraction in sales. Net profit moved from a small gain of €222 in 2023 to a loss of €3.3K in 2024 and €8.4K in 2025, with the latest profit margin at -14.1%. The balance sheet also weakened over the period: total assets fell from €59.8K in 2023 to €42.9K in 2024 and €6.5K in 2025, while equity declined from €22.5K to €14.9K and then to €6.5K. The latest equity ratio was 100.0%, reflecting the very small year-end asset base. Asset turnover in 2025 was 9.13x, indicating a high level of revenue relative to assets, and revenue per employee was €19.9K. Overall, the 2025 results point to lower turnover and continued losses after a modestly profitable 2023.